Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R MENDEZ

Showing results (251-260 of 260) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 260 results.
AIDS Care|December 12, 2007
Unhealthy behaviours for self-management of HIV-related peripheral neuropathyP K Nicholas, J G Voss, I B Corless, et al.
Journal of the American Veterinary Medical Association|September 6, 2024
Surgery and postoperative definitive radiotherapy for management of canine soft tissue sarcoma: a multi-institutional retrospective study of 272 dogs (2010-2020)Isabella M Hildebrandt, Owen T Skinner, Megan A Mickelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2001
Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican populationL A McInnes, S K Service, V I Reus, et al.
Nature Biomedical Engineering|July 18, 2025
Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreadingSadeem Qdaisat, Brandon Wummer, Brian D Stover, et al.
The Journal of Clinical Investigation|July 1, 2025
Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor responseHaipeng Tao, Dongjiang Chen, Changlin Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
mRNA aggregates harness danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Nature|October 22, 2025
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockadeAdam J Grippin, Christiano Marconi, Sage Copling, et al.
Medrxiv : the Preprint Server for Health Sciences|April 22, 2024
<i>De novo</i> variants in the non-coding spliceosomal snRNA gene <i>RNU4-2</i> are a frequent cause of syndromic neurodevelopmental disordersYuyang Chen, Ruebena Dawes, Hyung Chul Kim, et al.
Nature|July 11, 2024
De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndromeYuyang Chen, Ruebena Dawes, Hyung Chul Kim, et al.
Pageof 26

Showing results (251-260 of 260) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 260 results.
AIDS Care|December 12, 2007
Unhealthy behaviours for self-management of HIV-related peripheral neuropathyP K Nicholas, J G Voss, I B Corless, et al.
Journal of the American Veterinary Medical Association|September 6, 2024
Surgery and postoperative definitive radiotherapy for management of canine soft tissue sarcoma: a multi-institutional retrospective study of 272 dogs (2010-2020)Isabella M Hildebrandt, Owen T Skinner, Megan A Mickelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2001
Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican populationL A McInnes, S K Service, V I Reus, et al.
Nature Biomedical Engineering|July 18, 2025
Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreadingSadeem Qdaisat, Brandon Wummer, Brian D Stover, et al.
The Journal of Clinical Investigation|July 1, 2025
Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor responseHaipeng Tao, Dongjiang Chen, Changlin Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
mRNA aggregates harness danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Nature|October 22, 2025
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockadeAdam J Grippin, Christiano Marconi, Sage Copling, et al.
Medrxiv : the Preprint Server for Health Sciences|April 22, 2024
<i>De novo</i> variants in the non-coding spliceosomal snRNA gene <i>RNU4-2</i> are a frequent cause of syndromic neurodevelopmental disordersYuyang Chen, Ruebena Dawes, Hyung Chul Kim, et al.
Nature|July 11, 2024
De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndromeYuyang Chen, Ruebena Dawes, Hyung Chul Kim, et al.
Pageof 26